Cerebellar granule neuronal progenitors (GNPs) are the precursors of cerebellar granule cells (CGCs) and are believed to be the cell of origin for medulloblastoma (MB), yet the molecular mechanisms governing GNP neurogenesis are poorly elucidated. Here, we demonstrate that storkhead box 1 (Stox1), a forkhead transcriptional factor, has a pivotal role in cerebellar granule neurogenesis and MB suppression. Expression of Stox1 is upregulated along with GNP differentiation and repressed by activation of sonic hedgehog (SHH) signaling. Stox1 exerts its neurogenic and oncosuppressing effect via direct transcriptional repression of Math1, a basic helix-loop-helix transcription activator essential for CGC genesis. This study illustrates a SHH-Stox1-Math1 regulatory axis in normal cerebellar development and MB formation.
Postnatal cerebellum is a supreme model to study neurogenesis owing to its simple and well-defined laminar structure. Cerebellar granule cells (CGCs) differentiated from granule neuronal progenitors (GNPs) are the most abundant neuronal cell type in the central nervous system. 1 The renewal expansion and differentiation of GNPs are intricately regulated spatiotemporal processes. [2] [3] [4] GNPs proliferate actively on the cerebellar surface after birth to generate the external granule layer (EGL). 5 EGL peaks at postnatal day 7 and persists until the 3rd week in mice. We demonstrated in our recent study that GNPs undergo mostly symmetric division during early postnatal EGL development, and switch gradually to asymmetric division to produce one GNP and one intermediate cell that sequentially exits cell cycle and differentiates. 6 The differentiated CGCs extend the parallel and radial fibers, then migrate inward from EGL through the molecular layer (ML) and Purkinje cell layer (PL) to form the internal granule layer (IGL). 7 Aberrant proliferation and/or blocked differentiation of GNPs can lead to the development of MB, the most deadly brain cancer in children. Signaling pathways that act to control normal cerebellar neurogenesis are often deregulated in MB oncogenesis, yet the key molecules involved remain poorly identified. Based on the transcriptional profiling of human MB samples, MBs are classified into four molecular subtypes with distinct mRNA expression signatures associated with sonic hedgehog, WNT, Myc signalings or undefined genetic anomalies. [8] [9] [10] SHH, secreted by Purkinje cells, is a crucial cytokines in promoting GNP amplification and inhibiting differentiation through downstream genes, such as Gli1, Math1, Ccnd1 and MycN. 11 SHH signaling pathway stands out as the most attractive therapeutic target for MB, as it is the most prevalent molecular subtype of MB. Activation of SHH pathway by smothened (SMO) or Patched gene deletion led to MB development in mouse models. 12, 13 Although small molecule SHH pathway inhibitors have been shown to effectively suppress MB in the mouse and human, drug resistance and aggressive disease remission inevitably occur, which are mainly caused by mutations in SMO. 14, 15 Therefore, novel targets are in urgent need for the treatment of MBs with SHH signature.
Math1, a basic helix-loop-helix (bHLH) transcription factor specifically expressed in the proliferating GNPs, is a commonly used cerebellar EGL marker. 16, 17 It is required for both the expansion and differentiation suppression of GNPs. In addition, Math1 expression is markedly increased in the SHH-activated subtype of MB. 12, 18 It was reported that Math1 acts in the SHH MB development by modulating the expression of cell cycle progression genes Ccnd2 and SHH downstream signaling genes Gli2. 19, 20 Bone morphogenic proteins (BMPs) and Wnt signaling have been demonstrated to posttranslationally regulate the Math1 protein abundance through proteasome-mediated degradation in MB or colon cancer.
Still, much is unknown about the key component in the transcriptional activation or repression of Math1 gene in morphogenic or oncogenic cerebellum development.
Storkhead box 1 (Stox1), a winged helix transcription factor closely related to the forkhead protein family, was originally found to be associated with the preeclampsia disorder characterized by gestational hypertension and proteinuria. 22 It was recently reported that Stox1 is abundantly expressed in the brain and upregulated in the Alzheimer's disease.
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HAM1, the ortholog of Stox1 in the c. elegans, has been shown to control the neuroblast cell fate by regulating the spindle position and myosin polarization. 24 Recent study suggested that the role of HAM1 or Stox1 in neuronal migration appeared to be conserved between C. elegans hermaphrodite specific neurons and Xenopus neural crest cells. 25 However, the role of Stox1 in mammalian neurogenesis is poorly defined. In this study, we explore the role of Stox1 in the cerebellum neurogenesis and MB development.
Results
Stox1 is expressed in granule neurons of EGL in postnatal developing cerebellum. We first determined the expression pattern of Stox1 in the developing cerebellum.
Cerebella from postnatal day P0, P6, P14, P21 and P60 were harvested for immunoblotting. As shown in Figure 1a , the expression of Stox1 in mouse cerebellum increased at the first 2 weeks after birth, but declined later on. Owing to the lack of high-quality anti-Stox1 antibody suitable for immunostaining of tissue section, we utilized quantitative RT-PCR and immunoblotting to evaluate the expression level of Stox1 in different compartments of cerebellum fractionated by percoll gradient sedimentation or flow cytometry sorting. Cerebella of day 6 were collected and digested with papain followed by 35%/60% percoll gradient centrifugation. The GNPs from EGL were enriched at the interface between 35 and 60% percoll with a purity 490%, whereas the remaining cerebellar cells mainly from Purkinje's cells and interneurons stayed at the top of the gradient. 26 As shown in Figure 1b , strong expression of Stox1 was found in EGL. EGL is comprised of proliferating GNPs and newly differentiated Dcx-expressing granule neurons. 27 To further determine the expression pattern of Stox1 in EGL, we performed quantitative RT-PCR of flow cytometry sorted the Dcx-positive and -negative CGCs from Dcx-DsRed mice. Stox1 was more abundantly expressed in newly differentiated Dcx-positive granule neurons than Dcx-negative GNPs (Figure 1c ). In addition, GNPs from Math1-GFP transgenic mouse were enriched and subjected to in vitro differentiation for 2 days. Quantitative RT-PCR demonstrated an upregulation of Stox1 and Dcx along the differentiation of GNPs (Figure 1d ). Taken together, Stox1 was strongly expressed in the EGL of the postnatal cerebellum, with the highest level detected in Dcxpositive inner EGL granule neurons.
The expression of Stox1 is modulated by SHH signaling. It was shown previously that the SHH pathway has a crucial role in cerebellar granule neurogenesis. 1 In the developing cerebellum, proliferation of GNPs and the expression of GNP marker Math1 are stimulated with SHH signaling. 28 We therefore tested if Stox1 was modulated by the SHH signal pathway. As shown in Figure 2a , treatment of dissociated cultures of GNPs with SHH led to enhanced expression of Math1 and Ccnd1, whereas SHH stimulation resulted in suppressed expression of differentiated granule neuron maker Tuj1. Interestingly, the expression of Stox1 was significantly repressed in SHH treated primary GNPs (Figures 2a  and b) . Addition of a SHH signaling inhibitor cyclopamine compromised the impact of SHH treatment on the expression of Stox1, Math1, Ccnd1 and Tuj1 (Figures 2a and b) , suggesting a SHH signaling specific effect on the modulation of Stox1 expression.
Stox1 promotes the differentiation of cerebellar granule progenitor cells. GNPs are located at EGL in the postnatal mouse cerebellum, which continue to proliferate and differentiate during the postnatal 2-3 weeks.
1 Math1 is specifically expressed in GNPs and frequently used as a GNP marker, 29, 30 whereas Dcx is found to be expressed specifically in the early differentiated GNPs. [31] [32] [33] To analyze the biological function of Stox1 in postnatal cerebellar neurogenesis, we constructed a Stox1-expressing adenovirus that co-expressed tomato red fluorescent protein as a reporter. Math1-GFP and Dcx-DsRed reporter mice in which the Math1 or Dcx expressing granule neurons can be readily identified using respective fluorescent protein were introduced from the Jackson Laboratory. 30, 33 GNPs from day 6 Math1-GFP reporter mice were purified by percoll gradient sedimentation method, 34 plated on poly-D-lysine coated plates, and then infected with Stox1-expressing adenovirus. Stox1 overexpression was validated by quantitative RT-PCR and immunobloting (Figure 3a) . Infected GNPs were collected at 48 h and subjected to flow cytometric analysis of the Math1-GFP fluorescent intensity. As shown in Figure 3b , the Math1-GFP level was reduced in Stox1-overexpressing GNPs (Figure 3b ). Consistently, quantitative PCR revealed a significant downregulation of Math1 mRNA level in Stox1 adenovirus-infected GNPs. In contrast, overexpression of Stox1 resulted in an upregulation of the differentiated CGC markers including Dcx, Tuj1, Neurod1 and NeuN (Figure 3c ). In line with that, immunofluorescent staining showed enhanced generation of Dcx and Tuj1-positive cells from Stox1-overexpresing GNPs, suggesting a neurogenic effect of Stox1 (Figure 3d ).
To further test the hypothesis that Stox1 functions as a positive regulator in GNP differentiation, we used a factor in the cerebellum. Considering cell cycle exit and differentiation of GNPs are usually paralleled biological processes, we explored whether Stox1 affected the proliferation pattern of GNPs. As shown in Figure 4f , Stox1 knockdown resulted in a strikingly increased mitotic activity in GNPs, determined by elevated percentage of cells incorporated with EdU. Consistently, the expression of Ccnd1, a key factor in promoting cell cycle progression, was significantly elevated upon Stox1 knockdown, whereas the expression of cell cycle inhibitors p18, p21 and p27 were downregulated in shStox1 adenovirus-infected GNPs (Figure 4g ).
Stox1 serves as a transcriptional suppressor of Math1.
Stox1 is a member of the forkhead transcriptional factor family whose canonical target DNA-binding sequence is RYMAAYA. 35, 36 Using this sequence, we did in silico analysis of key genes involved in GNP proliferation and differentiation in searching for potential Stox1 downstream targets. Interestingly, we found multiple potential Stox1-binding sites in the cis-regulatory region of Math1 gene. It was previously reported that two conserved fragments (referred to as enhancer A and enhancer B) within the 1.7 kb fragment at 3.4 kb 3' of the Math1-coding region, sufficient for driving a lacZ reporter to recapitulate the endogenous Math1 expression in mice, was the key cis-regulatory element of Math1.
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To test if Stox1 functioned as a trans-acting factor of Math1, we took advantage of a reporter plasmid containing GFP coding sequence driven by the 1.7 kb Math1 cis-regulatory fragment comprised of enhancer A, enhancer B and the sequence in-between (termed as fragment C) (Figure 5a ). Co-transfection of the Math1-GFP reporter plasmid and Stox1-expressing adenovirus led to repressed expression of GFP, whereas infection of shStox1 adenovirus resulted in increased GFP expression in GNPs (Figure 5a ). These data were confirmed by luciferase assays showing that Stox1 negatively regulated the luciferase reporter driven by the 1.7 kb Math1 cis-regulatory element (Figure 5b ). Collectively, these data suggested that Stox1 acted as a tran-regulatory It is in agreement with the previous findings that enhancer A and enhancer B exhibited redundant activities in governing Math1 expression. 37 We further designed four pairs of primers that flanked the putative Stox1-binding sites in Math1 enhancers for chromatin immunoprecipitation (ChIP) (Figure 5c ). As showed in Figure 5c , there is a marked enrichment of Stox1 in Math1 enhancer A and enhancer B, suggesting a binding of Stox1 to the cisregulatory elements of Math1.
To pinpoint the DNA-binding sites of Stox1 in Math1 enhancer, we introduced mutations to the putative Stox1-binding site A1, A2, B1, B2 in enhancer A and enhancer B, respectively ( Figure 5d ). As shown in Figure 5d , compound mutations in A1 and A2 or mutation in B2 alone were able to compromise the transcriptional repression effect of Stox1, suggesting they are important for the regulation of Stox1 on Math1 transcription. Sequence alignment among site A1, A2 and B2 indicated MYHAACA is the potential recognition sequence. Further gel-shifting experiment is needed to verify whether Stox1 binds directly to the proposed DNA sequence. In addition, the transcriptional induction of Math1 gene by SHH stimulation can be significantly abrogated by Stox1 overexpression (Figure 5e ), further supporting the notion that Stox1 acted as a transcriptional suppressor of Math1.
Stox1 overexpression inhibits the Patched
+/ − tumor growth in vivo. Aberrant activation of SHH signaling occurs in~25% of human medulloblastomas (MBs) and accounts for the most prevalent MB subtype. 38, 39 Patched acts as a SHH receptor and inhibits SHH signaling by suppressing SMO. 11 Mutation of Patched leads to constitutive activation of the SHH pathway, deregulated GNP proliferation, blockage of GNP differentiation and spontaneous MB formation in Patched+/ − mice. 11 We demonstrated above that Stox1 functioned as a positive regulator of GNP differentiation. We then examined whether it was involved in MB development. As shown in Figures 6a and b, 
Discussion
We show in this study that Stox1 acts as a pivotal factor in cerebellar development and MB oncogenesis. In both of the two biological processes, Stox1 appears to exert its function through the same molecular mechanism, that is, through facilitating GNP differentiation by direct suppression of Math1 transcription. We demonstrate here that Stox1 binds to the Math1 enhancer and functions as a novel transcriptional suppressor of Math1. We further show that Stox1 is repressed by SHH activation and downregulated in Patched +/ − MB tissues. It has been reported that the increase of Math1 expression in SHH-activated subtype of MB is essential for the blockage of neuronal differentiation and initiation of MB. 19, 40 Our findings point to Stox1 as a crucial missing link between SHH signaling and Math1. Those data highlight a SHH-Stox1-Math1 regulatory axis in normal cerebellar development and MB formation. Stox1 is a winged helix transcription factor that structurally and functionally related to the Forkhead protein family. Several potential targets of Stox1 have been reported. CNTNAP2, a member of the neurexin family, is a negatively regulated target gene by Stox1 in Alzheimer's disease. 41 In addition, SFRS7
was found to be a target gene positively regulated by Stox1 in glial cells. 23 However, the core DNA-binding sequence has not been elucidated yet. We identify in the current study that Stox1 binds to the Math1 enhancer, probably at the MYHAACA recognition sequence similar to other forkhead family proteins. . (e) SHH stimulation leads to increased Math1 enhancer activity, which can be significantly compromised by Stox1 overexpression. Construct with Math1 enhancer fusion to luciferase reporter was transfected together with CMV-Renilla plasmid. Cells were treated with 1 μg/ml SHH and infected with Stox1-expressing adenovirus in indicated experimental group. Luciferase activity was assessed at 48 h later. (***Po0.001, *Po0.05, data are shown as means ± S.E.M.)
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Gel shift experiments using purified Stox1 protein will be needed to prove the direct binding of Stox1 with the proposed DNA sites.
In view of the suppressing effects of Stox1 on expression of Math1, it is important to point out that Math1, a bHLH transcription factor, is an important cell fate determinant not only during cerebellar development, but also during intestinal, inner ear and mechanosensary neuronal development. 29, [42] [43] [44] [45] Although Math1 appears to bind to the E-box of the DNA promoter regions of specific genes by a competition mechanism with Notch signaling molecules 46, 47 or upregulates other transcription factor genes, 19, 37, 48, 49 its upstream element is poorly known. The present study shows clearly that Stox1 as an upstream suppressor of Math1 in the cerebellum. It will be interesting to determine whether Stox1 also has a role in other tissues to modulate Math1 expression. In this regard, we demonstrated in a recent paper that Stox1 promotes proliferation of inner ear epithelial cells though elevated Akt signaling pathway. 50 It is also reported that Stox1 acts as a transcriptional activator of cyclin B1 and enhances mitotic entry of glioma cells. 51 Interestingly, in the current study, our data indicated that Stox1 is a negative regulator of neuronal progenitor proliferation in the cerebellum. Ectopic expression of Stox1 leads to GNP differentiation and MB inhibition. Transcriptional factors often work in complex. The distinct roles of Stox1 in different tissues are presumably owing to the presence of other co-factor or epigenetic modifiers in each specific cellular context. Previous study showed that Neurod1, Zic1 and Hic1 are possible transcriptional suppressor of Math1 in the cerebellum. [52] [53] [54] It remains to be determined whether those known factors interact with Stox1 in the regulation of Math1 transcription.
SHH-activated MB constitutes the most frequently detected molecular subtype of MB, therefore making SHH signaling related molecules the most promising therapeutic targets. However, drug resistance and disease relapse due to SMO mutations remain to be a major challenge for the application of current SHH receptor antagonists. 14, 15 Stox1, by its capacity to suppress the expression of Math1, the key effector of SHH signaling, may represent an attractive new target in SHHactivated subtype of MBs.
Methods and Materials
Mouse models. All experimental mice were housed in the pathogen-free animal center at Renji Hospital, Shanghai Jiaotong University with controlled temperature and humidity. Math1-GFP transgenic mice were a gift from Dr. Jane Johnson at University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA. Dcx-dsRed (009655) and Patched +/ − (003081) mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All animal experimental protocols were approved by the Animal Research Ethics Committee of Renji Hospital.
Isolation and culture of GNPs. GNPs were isolated from postnatal day 3 or day 6 mouse cerebellum according to the procedures described before. 3, 34 In brief, the dissected cerebella were digested with 2 mg/ml papain (Sigma, St. Louis, MO, USA) and 0.1% DNase I (Roche, Indianapolis, IN, USA) for 15 min, then filtered with a 70 μm cell stainer (Millipore, Billerica, MA, USA). The suspension of single cells was gently placed on the 35%/60% percoll gradient and was subjected to centrifugation for 10 min at 1800 × g. The GNPs were collected at the interface between 35 and 60% percoll. Dissociated GNPs were maintained in Neurobasal medium (Gibco, Waltham, MA, USA) containing B27 supplement (Gibco), 1 mM glutamine (Sigma), 100 U/ml penicillin/streptomycin, 0.45% D-glucose and 25 mM KCL in 1 mg/ml poly-d-lysine (Sigma) coated plates. For adenovirus infection, GNPs were incubated with adenovirus for 4 h and replaced with fresh culture medium. RNA isolation and quantitative RT-PCR. Total RNA was extracted using TRIzol reagent according to the manufacture's instruction. The cDNA syntheses were reverse transcribed from total RNA with PrimeScript RT reagent (Takara, Dalian, China Luciferase assays. Math1 enhancer luciferase constructs were co-transfected with CMV-Renilla plasmid (Promega, Madison, WI, USA) using lipofectamine 3000 transfection reagents (Roche). Forty-eight hours after transfection, cells were lysed and analyzed with the Dual-Luciferase Reporter Assay System (Promega).
Xenograft of
Luciferase activity values were normalized to the Renilla value.
ChIP assay. The N2A cells were transfected with pETP-flag-Stox1 plasmid. Forty-eight hours after transfection, cells were harvested and fixed with 1% formaldehyde. ChIP assay was performed using EZ-ChIP Kit from millipore according to the manufacturer's instruction. Antibody against FLAG (Sigma) was used to immunoprecipitate the Stox1-DNA complex. Semi-quantitative PCR was conducted to assess the enrichment of Stox1 in indicated Math1 cis-regulatory elements. The primers for PCR amplification were provided in the following table.
Forward Reverse
Immunofluorescent staining. The GNPs were cultured on the poly-D-lysine coated glass cover slides. For immunofluorescent stainings, the slides were first fixed in 4% paraformaldehyde for 10 min, then treated with 0.5% Triton X-100 for 15 min and blocked with 10% donkey serum for 1 h at room temperature. Indicated primary antibody was then applied to the overnight at 4°C. After washing with PBS for three times, slides were incubated with secondary antibody for 1 h at room temperature. After extensive washing with PBS, slides were mounted with mounting medium containing DAPI (Life Technologies, Waltham, MA, USA). Antibodies used in the immunofluorescent staining experiments were rabbit anti-Stox1 Edu assay. GNPs for Edu assay were cultured in suspension with SHH (1 μg/ml) to retain the proliferation ability. After 4 h of adenovirus infection, the Plasmid constructs. The Math1 enhancer GFP plasmid was kindly shared by Dr. Jane Johnson. 37, 55 The full-length or truncated Math1 enhancer were amplified by PCR from the Math1 enhancer GFP plasmid, and then cloned to a minimal promoter driven luciferase reporter pGL3.G basic, respectively. The mutations of enhancer A1, A2, B1 and B2 were performed by PCR directly mutating the target sequence on enhancer A, enhancer B as showed in Figure 3 . The primers for luciferase constructs cloning were provided in the following table. For the adenoviruses of Stox1 overexpression and knockdown, the cDNA or shRNA sequence of Stox1 was cloned to the adenoviral vector pAVsi 1.1. The sequence of shStox1 is GCTGTGCTATAGCTGATAT. 
